Presentations

  1. Symposium European Conference of Tobacco and Health 2011. Amsterdam, the Netherlands. Nicotine vaccination: a preview. The trial, the brain, societalcontext and the tobacco control community. CP. Van Schack MD, PhD, P. Hoogsteder MD, A. van Dorp MD, A. Wolters Mphil, E. van Rijswoud MSc.
  2. National AIOTHO-day (Arts in Opleiding tot Huisarts Onderzoeker) 2011, Utrecht, the Netherlands. De effectiviteit van een nicotinevaccin om te stoppen met roken.
  3. SRNT Europe (Society for Researh on Nicotine and Tobacco) 2012, Helsinki, Finland. Study design and preliminary results of a phase 2-b RCT on the efficacy of a nicotine vaccine co-administered with varenicline to stop smoking.
  4. ECNP-consultation meeting (European College for Neuropharmacology) 2013, Nice. France. Study design and preliminary results of a phase 2-b RCT on the efficacy of a nicotine vaccine co-administered with varenicline to stop smoking.
  5. SRNT Europe (Society for Researh on Nicotine and Tobacco) 2014, Santiago de Compostella, Spain. Efficacy of the nicotine vaccine 3’-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo controlled trial.